Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clove Oil and Menthol Lozenges for Post-extubation Sore Throat
NCT06811051Phase 1Enrolling by invitation
- Sponsor
- Istanbul Atlas University
- Start
- Jan 2025
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of l-Menthol and clove oil in postoperative sore throat (POST) (3 arms), sponsored by Istanbul Atlas University. Primary endpoints: Visual Analog Scale Pain Score and Incidence of Sore Throat. Started Jan 2025; status: enrolling by invitation.
02
Drugs
l-Mentholclove oil
03
Conditions
postoperative sore throat (POST)
Beyond the preview
Go deeper on NCT06811051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06811051.